PerkinElmer Sees Convergence, Growth Around Newborn Screening, Proteomics | GenomeWeb

PerkinElmer expects an “explosion” in the US in the screening of infants for metabolic diseases, a trend that it believes will not only drive double-digit revenue growth for its neonatal screening business in 2005, but also accelerate its proteomics business, executives said last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.